Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

M&A (Merger & Acquisition) activity slows, but there's no stopping the big spenders

This article was originally published in Clinica

Executive Summary

Medical device and diagnostics companies pledged around $16.5 billion on acquisitions last year. Deals worth a further $2 billion were proposed, but collapsed at various stages. The total, which does not include deals where financial details were not disclosed, is down from the previous year's $18 billion, but impressive nonetheless, Imogen Daulby reports The big companies kept on spending. Tyco International lived up to its acquisitive reputation, propelling itself up the medical device rankings with the $4.2 billion purchase of Mallinckrodt to complement recent shopping trips. Philips spent $1.2 billion for a 60% stake in medical transcription company Medquist, before finishing the year with a flourish by buying ADAC and Agilent Technologies for a total of over $2.1 billion in one week in November.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel